By understanding the role of each of these facets, clinicians can carefully tailor GLP-1RA treatment strategies in IBS to optimize safety, adherence and long-term outcomes
You need that accumulation period
Stay updated with our latest articles, expert insights, and inspiring stories
FDA Approves Wegovy to Reduce Heart Disease and Stroke Risk in People With Obesity The FDA has now approved Wegovy to reduce cardiovascular risk in people with obesity, in a label expansion based on results from Novo Nordisks SELECT trial
However, the Internet is filled with unsubstantiated claims that the peptide can cause unique and proven benefits such as: Improvements in muscle mass and muscle building body fat loss and reduced body weight improved body appearance faster recovery from injuries improved energy levels better physical performance increased ligament strength better muscle recovery after workouts improved cognition Improved bone density tissue regenerative properties The only plausible health benefits supported by any research are those observed in test animals, including reduced muscle damage during activity, muscle-sparing effects, increased organ growth, and weight gain